Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Mitochondrial Gridlock—Syntaphilin Puts Brakes on Axonal Transport
11 January 2007. You can’t keep a good mitochondrion down. Or maybe you can. In today’s Cell, researchers led by Zu-Hang Sheng at the National Institute for Neurological Disorders and Stroke report that the protein syntaphilin docks mitochondria to microtubules, impeding their transport and preventing their delivery to synapses. Genetically ablating syntaphilin boosts the mobility of mitochondria and enhances short-term facilitation, suggesting that syntaphilin may play a role in regulating neural activity, the scientists report. The finding may help researchers understand the relationship between defective mitochondrial transport and neurological and neurodegenerative disorders.

Being energy hogs, neurons are packed with mitochondria, particularly their synapses. Sheng and colleagues previously showed that syntaphilin can suppress presynaptic function (see Lao et al., 2000), which prompted them to go after the function of the protein. Using immunohistochemistry, first author Jian-Sheng Kang and colleagues found that syntaphilin (SNPH) occurs mostly in axons. Furthermore, using cultured hippocampal neurons, they found that the majority of SNPH colocalized with axonal mitochondria, and that deleting an axon-sorting domain redistributed SNPH into mitochondria in various other cellular locales, including the soma and dendrites. The finding suggests a specific relationship between wild-type syntaphilin and axonal mitochondria.

To test if that relationship might affect mitochondrial transport, Kang and colleagues observed the organelles with time-lapse confocal microscopy. They labeled mitochondria with red fluorescent protein (DsRed) and syntaphilin with green fluorescent protein (GFP). The researchers found that while 38 percent of axonal mitochondria are normally on the move, mitochondria bound to GFP-SNPH were stationary. It appears that SNPH binding to mitochondria locks them to microtubules, since SNPH lacking its microtubule binding domain did not impede mitochondrial motion. In fact, by simply tacking syntaphilin’s microtubule binding domain to the mitochondrial outer membrane protein TOM22, the researchers were able to block transport of the organelles. Interestingly, the syntaphilin microtubule binding domain is unlike any other known microtubule binding protein, suggesting that “SNPH likely acts as a docking receptor specific for axonal mitochondria through a unique interaction with the microtubule-based cytoskeleton,” write the authors.

Why does the SNPH-mitochondrial interaction matter? To address this, the authors made SNPH knockout mice. Both homo- and heterozygous strains were viable and fertile. Though their overall appearance was similar to wild-type mice, they did have subtle impairments in motor ability. For example, while the SNPH nulls balanced fine on the rotorod at constant speed, they faltered sooner than wild-type mice when the rod accelerated. As for axonal mitochondria, substantially more (76 percent) of them were on the move in hippocampal neurons cultured from SNPH knockouts than in neurons from wild-type mice (36 percent).

What might happen to the neuron when its mitochondria move more? For one, the density of axonal mitochondria drops (~ 1 per 10 μm in SNPH KOs versus 1.7 in wild-type); for another, the ratio of anterograde to retrograde mitochondrial movement changes from 1.27 to 1.03. These two changes “suggest that the SNPH-mediated docking/retention contributes to the maintenance of proper mitochondrial density in axons,” write the authors. Synapses also appear to be affected. The proportion of presynaptic boutons with proximal mitochondria within 0.5 μm goes down from 57 percent to 33 percent in SNPH knockouts, though the density of boutons stays normal. Given the primary role of mitochondria as energy providers, their failure to dock in and around synapses could deprive some of much needed ATP. The authors suggest this might be particularly significant for neurons with long axonal processes such as motor neurons.

Could the redistribution of mitochondria in SNPH null animals affect synaptic transmission? To test this, the authors measured excitatory post-synaptic currents (EPSC) in cultured hippocampal neurons. They found that while basal activity was normal in SNPH-negative neurons, a train of high-frequency pulses induced enhanced currents that indicate short-term facilitation. “One possible explanation for this observation is a rapid buildup of intracellular [Ca2+] in presynaptic terminals during intensive stimulation,” suggest the authors. In support of this, they demonstrated increased Ca2+ using fluorescent imaging and were able to abolish the enhanced short-term facilitation phenotype using the calcium chelator EGTA-AM. This would be in keeping with a proposed role for mitochondria in calcium homeostasis: mitochondria help balance calcium at some synapses by mopping up Ca2+ released by tetanic stimulation (see Jonas et al., 2006).

Though Sheng and colleagues previously reported that syntaphilin is involved in synaptic endocytosis (see Das et al., 2003), these findings also support a role of syntaphilin in docking mitochondria to microtubules and regulating their motility. “Such a mechanism may enable neurons to maintain proper densities of stationary mitochondria within axons and in the proximity of synapses," write the authors. Given that defective mitochondrial transport has been implicated in Charcot-Marie-Tooth Disease (see Baloh et al., 2007), Huntington disease (see Trushina et al., 2004), and potentially other neurodegenerative disorders (see for review Stokin and Goldstein, 2006), the findings may help researchers more fully understand the role of mitochondrial transport in neurons and neurologic disorders.—Tom Fagan.

Reference:
Kang J-S, Tian J-H, Pan P-Y, Zald P, Li C, Deng C, Sheng Z-H. Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation. Cell 2008 January 11;132:137-148. Abstract

 
Comments on News and Primary Papers
  Comment by:  Akihiko Takashima, ARF Advisor
Submitted 23 January 2008  |  Permalink Posted 23 January 2008

We know, based on Mandelkow’s and Hirokawa’s work, that accumulation of tau in neurons inhibits axonal transport, and may affect synaptic function. Hyperphosphorylation of tau detaches tau from microtubules, and restores axonal transport. However, subsequent formation of neurofibrillary tangles (NFTs) may also affect synaptic function, leading to neuronal dysfunction in disease. Therefore, tau is thought to have a dual role in synapse dysfunction. Sheng’s paper makes us reconsider the mode of mitochondrial axonal transport. Depletion of syntaphilin liberated mitochondria to a mobile state, and affected short-term facilitation in synapses, which means that detaching tau from microtubules by phosphorylation may affect synapse function by altering the mobile state of mitochondria. Indeed, in our recent manuscript, when tau was hyperphosphorylated with age in mice expressing human tau, the animals showed an impairment of spatial memory accompanied by synapse loss in the entorhinal cortex. If the state of tau alters the interplay between mitochondria and syntaphilin, the mobile state...  Read more

  Comment by:  M. Flint Beal
Submitted 23 January 2008  |  Permalink Posted 23 January 2008

The present paper makes an important contribution to understanding the proteins which are responsible for docking of axonal mitochondria and for controlling their mobility. The authors have identified a role for axon-targeted syntaphilin in mitochondrial docking through its interaction with microtubules. When they overexpressed syntaphilin, they report that axonal mitochondria lose mobility. They carried out elegant experiments in which they deleted the mouse syntaphilin gene. This resulted in a higher proportion of axonal mitochondria in the mobile state and reduced the density of mitochondria in axons. Electrophysiologically, the mutant neurons exhibited enhanced short-term facilitation during prolonged stimulation. This appears to be due to an effect on calcium signaling at the presynaptic boutons. They were able to rescue the phenotype by reintroducing the syntaphilin gene into the mutant neurons.

These are important findings in an area that is receiving increasing attention. It is likely that mitochondrial mobility and distribution may be important in neurodegenerative...  Read more

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad